Nexilico

BioCorteX

This digital medicine company develops a simulation platform to model drug-microbiome interactions for pharmaceutical and biotechnology clients to improve treatment outcomes.

Pragma Biosciences

This company develops a drug discovery platform using machine learning to identify microbiome-derived small molecules for pharmaceutical and healthcare partners.

Anto

This company develops foundation models to predict drug toxicity and efficacy by analysing gut microbiome data for pharmaceutical firms and drug developers.

Nuanced Health

This company develops a drug discovery platform using humanised microbiome mouse models to help pharmaceutical researchers account for human biological diversity in preclinical studies.

Florey Biosciences

This company develops engineered probiotics for patients taking antibiotics to protect gut microbiome health and prevent related medical conditions.

Xeomics

This company develops bioinformatics software and precision medicine platforms for doctors, pharmaceutical researchers, and national healthcare systems.

Metabogen

This company develops microbiome-based probiotics and pharmaceuticals for the probiotic and pharmaceutical industries to treat various health conditions.

PreComb

This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.